Safety and efficacy of brentuximab vedotin in patients with Hodgkin lymphoma or systemic anaplastic large cell lymphoma
C Vaklavas, A Forero-Torres - Therapeutic advances in …, 2012 - journals.sagepub.com
… can undergo ectodomain shedding generating an 85 kDa … to the tumor cells inducing durable
and complete regressions in … ALCL and one with angioimmunoblastic T-cell lymphoma. All …
and complete regressions in … ALCL and one with angioimmunoblastic T-cell lymphoma. All …
Targeting mitochondria with ClpP agonists as a novel therapeutic opportunity in breast cancer
R Wedam, YE Greer, DJ Wisniewski, S Weltz, M Kundu… - Cancers, 2023 - mdpi.com
… strategies to overcome such drug resistance and metastasis … -231 cell line upon treatment
with one of TR compounds revealed the … For instance, T cell metabolism changes dynamically …
with one of TR compounds revealed the … For instance, T cell metabolism changes dynamically …
Targeting SHMTs and MTHFDs in cancer: attractive opportunity for anti-tumor strategy
X Zhang, Z Wang - Frontiers in Pharmacology, 2024 - frontiersin.org
… Recent studies have revealed that MTHFD1/2 have been … a metabolic checkpoint determining
T cell differentiation. In Th17 … in various cancer types due to its role in generation of purine …
T cell differentiation. In Th17 … in various cancer types due to its role in generation of purine …
[PDF][PDF] The Diverse Roles of γδ T Cells in Cancer: From Rapid Immunity to Aggressive Lymphoma. Cancers 2021, 13, 6212
… γδ T-cell transformation, summarising the resulting γδ T-cell … , revealing non-redundant roles
of STAT5 homologs in fine-tuning γδ … inhibitors (methotrexate, pralatrexate), oral inhibitors of …
of STAT5 homologs in fine-tuning γδ … inhibitors (methotrexate, pralatrexate), oral inhibitors of …
Oncogenic mechanisms and therapeutic targeting of metabolism in leukemia and lymphoma
M Stahl, ZD Epstein-Peterson… - Cold Spring …, 2021 - perspectivesinmedicine.cshlp.org
… below, recent discoveries have revealed unexpected new … use of methotrexate and
pralatrexate in these diseases. … This suggests that IDH2 mutations may cause an arrest in T-cell …
pralatrexate in these diseases. … This suggests that IDH2 mutations may cause an arrest in T-cell …
[引用][C] Cancer Biology Research Literatures
M Herbert - metabolism - cancerbio.net
… gene therapy, based on an increase in the intensity of T cell … We revealed for the first
time that in lung fibroblasts the … , such as methotrexate and pralatrexate, are transported by …
time that in lung fibroblasts the … , such as methotrexate and pralatrexate, are transported by …
[引用][C] 3Nanomedicines for The Treatment
AK Deshantri, A Varela-Moreira, V Ecker… - Π-π Stacked Polymeric Micelles as …
Migration and adhesion associated molecules in lymphoma biology and their potential roles as biomarkers
S Lemma - 2017 - oulurepo.oulu.fi
… T-cell lymphoma PTCL NOS peripheral T-cell lymphoma, not … In rare cases, DLBCL shows
a tropism to CNS in forms of … deacetylase inhibitors, pralatrexate and monoclonal antibodies …
a tropism to CNS in forms of … deacetylase inhibitors, pralatrexate and monoclonal antibodies …
Recent advances in drug development targeting cancer metabolism
… anticancer drugs or antifolates are methotrexate, pralatrexate… anticancer efficacy is still not
revealed. Some examples of the … Also antitumor function of CD8+ T-cell is affected by changes …
revealed. Some examples of the … Also antitumor function of CD8+ T-cell is affected by changes …
HDAC3 inhibition promotes antitumor immunity by enhancing CXCL10-mediated chemotaxis and recruiting of immune cells
L Li, S Hao, M Gao, J Liu, X Xu, J Huang… - Cancer Immunology …, 2023 - AACR
… Our mechanistic research revealed that HDAC3 suppressed … Monoclonal cells cultured in
96-well plate were acquired by FACS … led to upregulated T-cell marker– and T-cell recruitment–…
96-well plate were acquired by FACS … led to upregulated T-cell marker– and T-cell recruitment–…